Lumingkit, Baby Girl .

HRN: 28-66-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/13/2026
03/20/2026
IV
37.5mg
Q24
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: